-
Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring
Desai, D. C., Dherai, A. J., Strik, A. & Mould, D. R., Apr 2023, In: Journal of clinical pharmacology. 63, 4, p. 480-489 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial
Strik, A. S., Löwenberg, M., Mould, D. R., Berends, S. E., Ponsioen, C. I., van den Brande, J. M. H., Jansen, J. M., Hoekman, D. R., Brandse, J. F., Duijvestein, M., Gecse, K. B., de Vries, A., Mathôt, R. A. & D’Haens, G. R., 2021, In: Scandinavian journal of gastroenterology. 56, 2, p. 145-154 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood Samples
Berends, S. E., Bloem, K., de Vries, A., Schaap, T., Rispens, T., Strik, A. S., Talwar, R., Löwenberg, M., DʼHaens, G. R. & Mathôt, R. A., 1 Apr 2020, In: Therapeutic drug monitoring. 42, 2, p. 289-294 6 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
